Stay updated on Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, indicating a small update to the page’s versioning. This change does not alter any study details, eligibility criteria, or other user-visible content.
    Difference
    0.0%
    Check dated 2026-09-01T19:15:09.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A new line '2016 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, signaling an NIH grant/contract reference associated with the trial. This addition expands the funding/administrative attribution attached to the study record.
    Difference
    0.0%
    Check dated 2026-08-25T20:22:29.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, signaling a new release of the documentation. This likely reflects small corrections or minor updates since the previous version.
    Difference
    0.0%
    Check dated 2026-08-11T22:06:04.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a small maintenance update to the page rather than a content change.
    Difference
    0.0%
    Check dated 2026-07-21T14:05:31.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision tag on the page was updated to Revision: v3.6.3, replacing the previous v3.6.0. This marks a new version of the page content without substantive changes to the trial details.
    Difference
    0.0%
    Check dated 2026-06-30T02:20:45.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Recruitment status was updated to 'No longer looking for participants', indicating enrollment is closed. The page also adds new help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and updates the revision to v3.6.0, along with changing the label from 'Intervention / Treatment' to 'Intervention/Treatment'.
    Difference
    0.2%
    Check dated 2026-06-15T20:59:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page.